Literature DB >> 28432761

Protein S-sulfhydration by hydrogen sulfide in cardiovascular system.

Guoliang Meng1,2, Shuang Zhao3, Liping Xie3, Yi Han4, Yong Ji2,3.   

Abstract

Hydrogen sulfide (H2 S), independently of any specific transporters, has a number of biological effects on the cardiovascular system. However, until now, the detailed mechanism of H2 S was not clear. Recently, a novel post-translational modification induced by H2 S, named S-sulfhydration, has been proposed. S-sulfhydration is the chemical modification of specific cysteine residues of target proteins by H2 S. There are several methods for detecting S-sulfhydration, such as the modified biotin switch assay, maleimide assay with fluorescent thiol modifying regents, tag-switch method and mass spectrometry. H2 S induces S-sulfhydration on enzymes or receptors (such as p66Shc, phospholamban, protein tyrosine phosphatase 1B, mitogen-activated extracellular signal-regulated kinase 1 and ATP synthase subunit α), transcription factors (such as specific protein-1, kelch-like ECH-associating protein 1, NF-κB and interferon regulatory factor-1), and ion channels (such as voltage-activated Ca2+ channels, transient receptor potential channels and ATP-sensitive K+ channels) in the cardiovascular system. Although significant progress has been achieved in delineating the role of protein S-sulfhydration by H2 S in the cardiovascular system, more proteins with detailed cysteine sites of S-sulfhydration as well as physiological function need to be investigated in further studies. This review mainly summarizes the role and possible mechanism of S-sulfhydration in the cardiovascular system. The S-sulfhydrated proteins may be potential novel targets for therapeutic intervention and drug design in the cardiovascular system, which may accelerate the development and application of H2 S-related drugs in the future. LINKED ARTICLES: This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28432761      PMCID: PMC5866969          DOI: 10.1111/bph.13825

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  86 in total

1.  Hydrogen sulfide anion regulates redox signaling via electrophile sulfhydration.

Authors:  Motohiro Nishida; Tomohiro Sawa; Naoyuki Kitajima; Katsuhiko Ono; Hirofumi Inoue; Hideshi Ihara; Hozumi Motohashi; Masayuki Yamamoto; Makoto Suematsu; Hitoshi Kurose; Albert van der Vliet; Bruce A Freeman; Takahiro Shibata; Koji Uchida; Yoshito Kumagai; Takaaki Akaike
Journal:  Nat Chem Biol       Date:  2012-07-01       Impact factor: 15.040

2.  Diallyl trisulfide protects against ethanol-induced oxidative stress and apoptosis via a hydrogen sulfide-mediated mechanism.

Authors:  Lian-Yun Chen; Qin Chen; Xiao-Jing Zhu; De-Song Kong; Li Wu; Jiang-Juan Shao; Shi-Zhong Zheng
Journal:  Int Immunopharmacol       Date:  2016-04-22       Impact factor: 4.932

3.  Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions.

Authors:  Nilkantha Sen; Bindu D Paul; Moataz M Gadalla; Asif K Mustafa; Tanusree Sen; Risheng Xu; Seyun Kim; Solomon H Snyder
Journal:  Mol Cell       Date:  2012-01-13       Impact factor: 17.970

4.  S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics.

Authors:  Katalin Módis; YoungJun Ju; Akbar Ahmad; Ashley A Untereiner; Zaid Altaany; Lingyun Wu; Csaba Szabo; Rui Wang
Journal:  Pharmacol Res       Date:  2016-08-20       Impact factor: 7.658

5.  H2S signals through protein S-sulfhydration.

Authors:  Asif K Mustafa; Moataz M Gadalla; Nilkantha Sen; Seyun Kim; Weitong Mu; Sadia K Gazi; Roxanne K Barrow; Guangdong Yang; Rui Wang; Solomon H Snyder
Journal:  Sci Signal       Date:  2009-11-10       Impact factor: 8.192

Review 6.  Regulation and role of endogenously produced hydrogen sulfide in angiogenesis.

Authors:  Antonia Katsouda; Sofia-Iris Bibli; Anastasia Pyriochou; Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Res       Date:  2016-08-26       Impact factor: 7.658

7.  The novel H2 S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium.

Authors:  Alice Marino; Alma Martelli; Valentina Citi; Ming Fu; Rui Wang; Vincenzo Calderone; Roberto Levi
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

8.  The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels.

Authors:  Stephen Ph Alexander; William A Catterall; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

9.  Hydrogen Sulfide Inhibits High-Salt Diet-Induced Renal Oxidative Stress and Kidney Injury in Dahl Rats.

Authors:  Pan Huang; Zhizhou Shen; Jia Liu; Yaqian Huang; Siyao Chen; Wen Yu; Suxia Wang; Yali Ren; Xiaohui Li; Chaoshu Tang; Junbao Du; Hongfang Jin
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

10.  MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN.

Authors:  Zun-Ping Ke; Peng Xu; Yan Shi; Ai-Mei Gao
Journal:  Oncotarget       Date:  2016-05-17
View more
  28 in total

1.  Hydrogen sulfide regulates muscle RING finger-1 protein S-sulfhydration at Cys44 to prevent cardiac structural damage in diabetic cardiomyopathy.

Authors:  Xiaojiao Sun; Dechao Zhao; Fangping Lu; Shuo Peng; Miao Yu; Ning Liu; Yu Sun; Haining Du; Bingzhu Wang; Jian Chen; Shiyun Dong; Fanghao Lu; Weihua Zhang
Journal:  Br J Pharmacol       Date:  2019-04-29       Impact factor: 8.739

Review 2.  A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator.

Authors:  Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-09-22       Impact factor: 5.858

3.  Spotlight on small molecules in cardiovascular diseases.

Authors:  Xin Wang; Yu Huang; Yong Ji
Journal:  Br J Pharmacol       Date:  2018-04       Impact factor: 8.739

4.  [Exogenous hydrogen sulfide improves erectile dysfunction by inhibiting apoptosis of corpus cavernosum smooth muscle cells in rats with cavernous nerve injury].

Authors:  Qinyu Zeng; Shuhua He; Liren Zhong; Li Wang; Fengzhi Cheng; Haibo Zhang; Jialiang Hui; Anyang Wei
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

Review 5.  Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure.

Authors:  Alexander Dietl; Christoph Maack
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 6.  Utility of NO and H2S donating platforms in managing COVID-19: Rationale and promise.

Authors:  Palak P Oza; Khosrow Kashfi
Journal:  Nitric Oxide       Date:  2022-08-24       Impact factor: 4.898

7.  S-nitrosylation of c-Jun N-terminal kinase mediates pressure overload-induced cardiac dysfunction and fibrosis.

Authors:  Miao Zhou; Ji-Yu Chen; Meng-Lin Chao; Chao Zhang; Zhi-Guang Shi; Xue-Chun Zhou; Li-Ping Xie; Shi-Xiu Sun; Zheng-Rong Huang; Shan-Shan Luo; Yong Ji
Journal:  Acta Pharmacol Sin       Date:  2021-05-19       Impact factor: 6.150

8.  New aspects of antiproliferative activity of 4-hydroxybenzyl isothiocyanate, a natural H2S-donor.

Authors:  Halina Jurkowska; Maria Wróbel; Dominika Szlęzak; Ewa Jasek-Gajda
Journal:  Amino Acids       Date:  2018-03-05       Impact factor: 3.520

9.  Allylmethylsulfide, a Sulfur Compound Derived from Garlic, Attenuates Isoproterenol-Induced Cardiac Hypertrophy in Rats.

Authors:  Soheb Anwar Mohammed; Bugga Paramesha; Yashwant Kumar; Ubaid Tariq; Sudheer Kumar Arava; Sanjay Kumar Banerjee
Journal:  Oxid Med Cell Longev       Date:  2020-06-11       Impact factor: 6.543

10.  Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation.

Authors:  Shu Song; Yue Ding; Guo-Liang Dai; Yue Zhang; Meng-Ting Xu; Jie-Ru Shen; Ting-Ting Chen; Yun Chen; Guo-Liang Meng
Journal:  Acta Pharmacol Sin       Date:  2020-08-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.